Membranous expression of HER2 was scored as 0 in 248 samples (77.3%), 1+ in 48 (15.0%), 2+ in 21 (6.5%), and 3+ in 4 (1.2%) according to the ASCO/CAP guidelines of breast cancer. Here, ERBB2 is linked to breast cancer.